Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Medicines register
Registers› Irish medicines ›Seretide 125 Evohaler 25 microgram/125 microgram/dose pressurised inhalation, suspension
Medicines register · Ireland

Seretide 125 Evohaler 25 microgram/125 microgram/dose pressurised inhalation, suspension

Authorisation PPA0465/091/005 · PCO Manufacturing Ltd.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
PCO Manufacturing Ltd. (all products →)
Active substances
Fluticasone propionate, SALMETEROL XINAFOATE
Clinical trials
2 clinical trials →
Dosage form
Pressurised inhalation, suspension
Route of administration
Inhalation use
ATC codes
R03AK, R03AK06
First authorised
06/02/2004
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC

Fluticasone propionate: supply and approvals

72 authorised products on the HPRA list contain Fluticasone propionate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

SALMETEROL XINAFOATE: supply and approvals

16 authorised products on the HPRA list contain SALMETEROL XINAFOATE. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 22 years (since 6 February 2004). The HPRA list does not say whether it is on sale.

Other medicines with Fluticasone propionate in Ireland

71 other products on the HPRA list contain Fluticasone propionate, from 16 licence holders; 27 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
AirFluSal Forspiro 50 microgram/250 microgram/dose, inhalation powder, predispensedRowex Limited,National authorisation (PA)Marketed
AirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensedRowex Limited,National authorisation (PA)Marketed
Azecort 137 micrograms/50 micrograms per actuation nasal spray, suspensionViatris Healthcare LimitedNational authorisation (PA)Marketed
Azelastine hydrochloride /Fluticasone propionate Rowex 137 micrograms/50 micrograms per actuation, nasal spray suspensionRowex Limited,National authorisation (PA)Marketed
Dymista 137 micrograms/50 micrograms per actuation, Nasal Spray SuspensionViatris Healthcare LimitedNational authorisation (PA)Marketed
Flixonase Allergy Relief 50 micrograms per dose Nasal SprayHaleon Ireland LimitedNational authorisation (PA)Marketed
Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation, SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed

All 72 products with Fluticasone propionate →

Other medicines with SALMETEROL XINAFOATE in Ireland

15 other products on the HPRA list contain SALMETEROL XINAFOATE, from 7 licence holders; 5 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Seretide 100 Diskus 50 microgram/100 microgram/dose inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Seretide 250 Diskus 50 microgram/250 microgram/dose inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Seretide 500 Diskus 50 microgram/500 microgram/dose inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspensionViatris LimitedNational authorisation (PA)Marketed
Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspensionViatris LimitedNational authorisation (PA)Marketed
AirFluSal MDI 25 microgram/125 microgram/dose pressurised inhalation, suspensionRowex Limited,National authorisation (PA)Not marketed
Salmeterol/Fluticasone 50 microgram/100 microgram/dose inhalation powder, pre-dispensedGenetic S.p.A.National authorisation (PA)Not marketed
Salmeterol/Fluticasone 50 microgram/250 microgram/dose inhalation powder, pre-dispensedGenetic S.p.A.National authorisation (PA)Not marketed
Salmeterol/Fluticasone 50 microgram/500 microgram/dose inhalation powder, pre-dispensedGenetic S.p.A.National authorisation (PA)Not marketed
Sametec Airmaster 50 microgram/ 100 microgram/ dose, inhalation powder, pre-dispensedClonmel Healthcare LtdNational authorisation (PA)Not marketed
Sametec Airmaster 50 microgram/ 250 microgram/ dose, inhalation powder, pre-dispensedClonmel Healthcare LtdNational authorisation (PA)Not marketed
Sametec Airmaster 50 microgram/ 500 microgram/ dose, inhalation powder, pre-dispensedClonmel Healthcare LtdNational authorisation (PA)Not marketed

All 16 products with SALMETEROL XINAFOATE →

Other substances in ATC group R03AK

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 12 other active substances share the group R03AK with this product:

Salmeterol (14) · Formoterol fumarate dihydrate (11) · Budesonide (7) · Formoterol fumarate (2) · Beclometasone dipropionate (2) · Beclometasone dipropionate anhydrous (1) · Fluticasone furoate (1) · Vilanterol (1) · Formoterol fumarate dihydrate (micronised) (1) · Formoterol fumatrate dihydrate (1) · Ipratropium bromide monohydrate (1) · Salbutamol (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

PCO Manufacturing Ltd. holds 287 products on the HPRA list, with 163 different active substances; 1 of the products is marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.